Skip to content

Santen and IAPB Partner to Advocate for Better Eye Health

Santen has joined IAPB as a Global Patron.
Published: 05.02.2021

February 5, 2021, Osaka, Japan – Santen Pharmaceutical Co., Ltd. (hereinafter, Santen) and The International Agency for the Prevention of Blindness (hereinafter, IAPB) today announced that Santen has joined IAPB as a Global Patron, as part of Santen’s new strategy towards 2030. Working together, Santen and IAPB will advocate to bring better eye health to all at global, country and regional levels.

We are pleased to announce our partnership with IAPB”, said Shigeo Taniuchi, President and CEO of Santen.  “Santen’s VISION towards 2030 seeks to orchestrate and mobilize key technologies and players around the world, to deliver happiness through vision. Santen’s work has highlighted to advancing ophthalmology and improving Quality of Vision (QOV) and Quality of Life (QOL) of people around the world. We are now keen to seek partnerships that will help multiply eye health impact – and the IAPB alliance presents a great opportunity to do so.”

We are delighted to welcome Santen as Global Patrons”, said Peter Holland, CEO, IAPB. “IAPB’s strength is bringing together the diversity of the eye health sector and catalysing positive change. Santen is a social innovator in vision and with their knowledge and expertise, we have the potential to achieve our shared goals for vision and eye health by 2030”.

Santen and IAPB will be working on the following priorities:

  • Advocating for vision as a global development priority, promoting the links between vision and the Sustainable Development Goals
  • Supporting IAPB global policy and advocacy activities
  • Promoting innovation in ophthalmology to accelerate positive change to bring better eye health and vision to more people around the world
  • Engaging in regional and country level activities that raise the profile of eye health and vision with key decision makers

About Santen

As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. For more information, please visit Santen’s website (

About IAPB

IAPB is the overarching alliance for the global eye health sector, with more than 150 organisations in over 100 countries working together for a world where everyone has universal access to eye care. IAPB believes in a world in which no one is needlessly visually impaired, where everyone has access to the best possible standard of eye health; and where those with irreparable vision loss achieve their full potential. Our key priorities are global advocacy, connecting knowledge and strengthening the network. For more information, please visit IAPB’s website (


Corporate Communications Group

Santen Pharmaceutical Co., Ltd.

E-mail: [email protected]   Tel. : +81-6-4802-9360